1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBCUrothelial Bladder CancerNot yet recruitingPhase 22026-06-25NCT07663747